Filing Details

Accession Number:
0000899243-18-003102
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-07 16:55:34
Reporting Period:
2018-02-06
Accepted Time:
2018-02-07 16:55:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566469 Nanthealth Inc. NH Services-Computer Processing & Data Preparation (7374) 273019889
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1706849 Allen Ronald Louks C/O Nanthealth, Inc.
9920 Jefferson Blvd.
Culver City CA 90232
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-06 10,000 $0.00 89,690 No 4 M Direct
Common Stock Disposition 2018-02-06 3,525 $3.02 86,165 No 4 F Direct
Common Stock Disposition 2018-02-06 6,475 $3.02 79,690 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-02-06 10,000 $0.00 10,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,000 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock.
  2. Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 40,000 RSUs vested on October 6, 2017, with the remaining 120,000 RSUs to vest monthly in equal amounts for 12 months, beginning on November 6, 2017. Upon vesting, the issuer will withhold shares sufficient to satisfy tax withholding obligations; the issuer will then be responsible for remitting a cash payment for the related withholding taxes; and the issuer will issue to the Reporting Person a net lower number of shares. In addition, upon vesting, the issuer and the Reporting Person have agreed that the issuer will repurchase the remaining shares at the then current market value.
  3. Pursuant to the terms of the grant, the Issuer repurchased the shares at a price per share equal to the closing price on the date of vesting.